BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 1827613)

  • 1. Double-blind comparison of etodolac and naproxen in the treatment of rheumatoid arthritis.
    de Queiros MF
    Clin Ther; 1991; 13(1):38-46. PubMed ID: 1827613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-blind, parallel-group evaluation of etodolac and naproxen in patients with acute sports injuries.
    D'Hooghe M
    Clin Ther; 1992; 14(4):507-16. PubMed ID: 1388091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Etodolac versus diclofenac: double-blind cross-over study in rheumatoid arthritis.
    Ciompi ML; Puccetti L; Bazzichi L; Remorini E; Marotta G
    Int J Clin Pharmacol Res; 1989; 9(3):217-22. PubMed ID: 2526101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind comparison of etodolac and piroxicam in the treatment of rheumatoid arthritis.
    Dick WC; Franchimont P; Veys E
    Clin Ther; 1993; 15(1):148-59. PubMed ID: 8458044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the efficacy and safety of etodolac and piroxicam in patients with rheumatoid arthritis. Etodolac Study 326 Rheumatoid Arthritis Investigators Group.
    Lightfoot R
    J Rheumatol Suppl; 1997 Feb; 47():10-6. PubMed ID: 9035015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An overview of the efficacy of etodolac in arthritic disorders.
    Bacon PA
    Eur J Rheumatol Inflamm; 1990; 10(1):22-34. PubMed ID: 2146130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness and safety of etodolac in treatment of rheumatoid arthritis: a multicentre two-months' open study.
    Puccetti L; Soletti A; Petrini G; Remorini E; Zuccotti M; Bazzichi L; Ciompi ML
    Int J Clin Pharmacol Res; 1990; 10(6):347-53. PubMed ID: 2151575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-blind comparison of etodolac and piroxicam in patients with rheumatoid arthritis.
    Schattenkirchner M
    Curr Med Res Opin; 1991; 12(8):497-506. PubMed ID: 1837260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the effectiveness and safety of etodolac in prolonged treatment of active osteoarthritis.
    Puccetti L; Ciompi ML
    Int J Clin Pharmacol Res; 1991; 11(3):143-58. PubMed ID: 1839736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Etodolac versus naproxen in rheumatoid arthritis: a double-blind crossover study.
    Waltham-Weeks CD
    Curr Med Res Opin; 1987; 10(8):540-7. PubMed ID: 2960494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of valdecoxib in treating the signs and symptoms of severe rheumatoid arthritis: a 12-week, multicenter, randomized, double-blind, placebo-controlled study.
    Gibofsky A; Rodrigues J; Fiechtner J; Berger M; Pan S
    Clin Ther; 2007 Jun; 29(6):1071-85. PubMed ID: 17692722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of valdecoxib and naproxen in the treatment of rheumatoid arthritis symptoms.
    Williams GW; Kivitz AJ; Brown MT; Verburg KM
    Clin Ther; 2006 Feb; 28(2):204-21. PubMed ID: 16678642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of etodolac compared with piroxicam in patients with degenerative joint disease of the knee.
    Dick WC; Bulstra S; Schardijn GH; Feenstra RM
    Clin Ther; 1992; 14(4):517-26. PubMed ID: 1388092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A six-month parallel group comparison of fenbufen and naproxen in the treatment of rheumatoid arthritis.
    Khan FM
    Clin Ther; 1983; 5(5):483-7. PubMed ID: 6352034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical efficacy and safety of Naprelan versus Naprosyn in the treatment of rheumatoid arthritis.
    Lisse JR
    Am J Orthop (Belle Mead NJ); 1996 Sep; 25(9 Suppl):21-9. PubMed ID: 8886214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind, comparative study of diflunisal and naproxen in the treatment of rheumatoid arthritis.
    Devereaux MD; Douglas WA
    Eur J Rheumatol Inflamm; 1983; 6(3):274-8. PubMed ID: 6391932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Etodolac, aspirin, and placebo in patients with rheumatoid arthritis: a 12-week study.
    Edwards W
    Clin Ther; 1983; 5(5):495-503. PubMed ID: 6225520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-blind crossover study to evaluate the efficacy of a single daily dose of naproxen in rheumatoid arthritis.
    Katona G; Vargas RB
    Eur J Rheumatol Inflamm; 1983; 6(3):233-41. PubMed ID: 6391928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. International experience with etodolac therapy for rheumatoid arthritis: an interim report of comparative efficacy.
    Briancon D
    Clin Rheumatol; 1989 Mar; 8 Suppl 1():63-72. PubMed ID: 2525985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valdecoxib is associated with improved dyspepsia-related health compared with nonspecific NSAIDs in patients with osteoarthritis or rheumatoid arthritis.
    Rabeneck L; Goldstein JL; Vu A; Mayne TJ; Rublee DA
    Am J Gastroenterol; 2005 May; 100(5):1043-50. PubMed ID: 15842577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.